HDR brachytherapy uses a highly radioactive source, often iridium-192 or cesium-137, which is temporarily placed within a special applicator that has been positioned in the treatment area. The procedure is usually performed in an outpatient setting. The radioactive source is controlled by a computer and is precisely placed to maximize the dose to the cancer cells while protecting normal tissues.
